Advantage Investment Management’s Biogen BIIB Stock Holding History

Advantage Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$17K	Hold	72	–	–	0.01%	544
2019 Q2	$17K	Buy	72 +45	+167%	+$10.4K	0.01%	557
2019 Q1	$6K	Buy	+27	New	+$8.5K	﹤0.01%	720
2016 Q2	–	Sell	-80	Closed	-$21K	–	869
2016 Q1	$21K	Hold	80	–	–	0.01%	452
2015 Q4	$25K	Hold	80	–	–	0.01%	435
2015 Q3	$23K	Hold	80	–	–	0.01%	419
2015 Q2	$32K	Hold	80	–	–	0.02%	402
2015 Q1	$34K	Hold	80	–	–	0.02%	381
2014 Q4	$27K	Buy	+80	New	+$25.9K	0.02%	379

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Advantage Investment Management's BIIB Position: Q3 2019 in Review

Advantage Investment Management held its Biogen (BIIB) position steady in Q3 2019 at 72 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #544.

Advantage Investment Management first reported a position in BIIB in Q4 2014 and has held it in 9 quarters since. The position peaked at $34K in Q1 2015. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Advantage Investment Management held 72 shares of Biogen worth $17K as of Q3 2019.
Advantage Investment Management left its Biogen share count unchanged in Q3 2019.
Biogen made up 0.01% of Advantage Investment Management's portfolio in Q3 2019, its #544 holding.
Advantage Investment Management first reported a position in Biogen in Q4 2014 and has held it in 9 quarters since.
Advantage Investment Management's Biogen position peaked at $34K in Q1 2015.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.